Introduction
============

Illnesses caused by foodborne pathogens are an increasingly critical public health concern ([@B53]). *Vibrio parahaemolyticus* is recognized as a major foodborne pathogen for causing gastroenteritis worldwide, especially in coastal countries and regions ([@B37]; [@B48]; [@B28]; [@B23]). Clinical symptom of *V. parahaemolyticus* infections include diarrhea, abdominal cramps, vomiting and fever, which also progresses to septicemia can sometimes lead to death in patients ([@B46]; [@B32]). In 1950, this pathogen was first discovered in Japan, which resulted 272 illnesses with 20 deaths ([@B12]). From 1997 to 2000, 84 food poisoning outbreaks caused by *V. parahaemolyticus* were recorded in Spain ([@B10]). From 2000 to 2008, it was reported around 35,000 *V. parahaemolyticus* infections annually in US ([@B15]). In China, during 2003 to 2008, this microorganism has caused 9041 illnesses and 3948 hospitalizations ([@B58]). It is essential to gather the epidemiological data of *V. parahaemolyticus* to reduce the burden of disease caused by this pathogen in China.

Virulence of *V. parahaemolyticus* is primarily attributed to the production of a thermostable direct haemolysin (TDH), TDH-related haemolysin (TRH) and two type III secretion systems, T3SS ([@B35]; [@B45]; [@B64]). TDH and TRH are encoded by the *tdh* gene and *trh* gene, respectively ([@B28]). Although the specific actions of these genes in human infection remain unknown, the relevance between pathogenicity of *V. parahaemolyticus* and the presence of *tdh* and *trh* is well recognized ([@B4]; [@B5]). Contamination of foods with *tdh*- and/or *trh*-positive *V. parahaemolyticus* strains is considered a public health risk ([@B41]). The two T3SS systems in *V. parahaemolyticus* are known as T3SS1 and T3SS2 ([@B55]). T3SS1 is encoded by the first pathogenicity island on chromosome I and is involved in cytotoxicity ([@B40]). T3SS2 is located on chromosome II and is also encoded by a pathogenicity island. As a newly identified type of secretion system, T3SS2 appears to be associated with enterotoxicity and cytotoxicity, in experiments conducted in vitro and in intestinal cell lines ([@B45]). Currently, it is possible to detect the presence of *tdh*, *trh* and T3SS genes in *V. parahaemolyticus* isolates by PCR-based methods ([@B56]).

*Vibrio parahaemolyticus* strains exhibit high genetic diversity due to high rates of recombination and mutation, which caused potential infection risk for human health ([@B34]). A number of molecular typing methods have been used to determine the molecular epidemiology of *V. parahaemolyticus*, and these methods include multilocus sequence typing (MLST), serotyping, and pulsed-field gel electrophoresis (PFGE) ([@B2]; [@B61]). MLST has proven to be powerful tool for investigating the prevalence and diversity of *V. parahaemolyticus* strains in recent years ([@B57]). MLST is based on the sequencing of seven housekeeping genes and can be analyzed directly via the internet ([@B13]). MLST is commonly used for identifying the relationship between isolates in public database and has proven to be an important method for investigation of the evolution and epidemiology of *V. parahaemolyticus* ([@B2]).

Antimicrobials are used in the treatment of infectious diseases and improper or enhanced application of antimicrobials leads to development of antimicrobial resistant (AMR) bacteria ([@B62]). The Economic Forum for Global Risks indicates that the problem of AMR is projected to be one of the greatest threats to human health in the future ([@B27]; [@B3]). The critical factors for the emergence of AMR are antimicrobial resistance genes (ARGs) which can be transferred by the horizontal gene transfer ([@B50]). ARGs are emerging contaminants posing a potential worldwide human health risk ([@B1]; [@B33]). It is vital to monitor the AMR and ARGs of *V. parahaemolyticus* strains, which can be used for disease management and reducing the burden of disease caused by this pathogen.

Shanghai is one of the largest prosperous cities in China with high annual consumption of seafood and many cases of *V. parahaemolyticus* infections ([@B65]; [@B43]), which have become a potential threat for human health. The researches for *V. parahaemolyticus* strains isolated from aquatic products are widely reported ([@B54]; [@B14]; [@B20], [@B19]; [@B33]; [@B21]; [@B63]; [@B66]), while studies on clinical isolates has been poorly documented ([@B65]; [@B43]).

The main objectives of this study are to monitor the virulence, genetic diversity and antimicrobial susceptibility of clinical *V. parahaemolyticus* isolates from Shanghai. We hope to provide reliable information, for assessing the genetic traits and the antimicrobial resistance risk of *V. parahaemolyticus* strains, and for better management of foodborne infections in Shanghai.

Materials and Methods {#s1}
=====================

Specimen Collection and Bacteria Isolation
------------------------------------------

A total of 1900 fecal specimens were collected by Shanghai hospital from patients who presented with acute diarrhea to gastroenteritis outpatient clinics during the period from January 2014 through to December 2015. These fecal samples were placed in sterile sealed plastic bags and stored at 4°C prior to further analysis. Confirmation of *V. parahaemolyticus* samples were performed using standard culture methods ([@B24]).

Briefly, 25 g of each fecal specimen was homogenized for 2 min in a stomacher 400 with 225 mL of alkaline peptone water (APW; Beijing Land Bridge Technology Company Ltd., Beijing, China) containing 3% NaCl, and incubated at 37°C for 16-18 h. After incubation, a loop from the top 1 cm was streaked onto thiosulfate-citrate-bile salts-sucrose (TCBS; Beijing Land Bridge Technology Company Ltd., Beijing, China) agar plates and incubated at 37°C for 18--24 h. Presumptive individual bacterial colony (green or blue green colony, 2--3 mm in diameter) were grown in 10 ml tryptic soy broth (TSB; Beijing Land Bridge Technology Company Ltd., Beijing, China) supplemented with 3.0% NaCl and incubated at 37°C for 18--24 h. After cultivation, the bacterial liquid and 50% glycerol in the proportion of 1:1 were placed in a glycerol tube and stored at --80°C for further analysis.

DNA Extraction
--------------

DNA extraction of all presumptive *V. parahaemolyticus* isolates was performed using the TIANamp Bacteria DNA Kit (Tiangen Biotech Beijing Co., Ltd, Beijing, China), in accordance to the manufacturer's recommended protocols and then stored it at --20°C prior to PCR analysis.

Identification of *Vibrio parahaemolyticus*
-------------------------------------------

The presumptive *V. parahaemolyticus* isolates were tested for the presence of the species specific gene *tlh* by using polymerase chain reaction (PCR). Detection of *tlh* gene was carried out using the primer *tlh*-F (5- AAA GCG GAT TAT GCA GAA GCA CTG -3) and *tlh*-R (5- GCT ACT TTC TAG CAT TTT CTC TGC -3) as specified in ([@B9]). The reaction mixture for this PCR assay was performed in 25 μL, containing 1 μL of DNA template, 12.5 μL of PCR Mix (Sangon Biotech, Shanghai, China), 9.5 μL of dd H~2~O and 1 μL of each primer. The thermal-cycling program is as follows: initial denaturation at 94°C for 3 min, 25 cycles of 94°C for 1 min, 60°C for 1 min and 72°C for 2 min, and a final extension at 72°C for 3 min. Finally, PCR products were analyzed by agarose gel electrophoresis.

We also chose the API 20E system (BioMerieux, Inc., Durham, NC, United States) and DBI-08 (Beijing Land Bridge Technology Company Ltd., Beijing, China) to analyze and identify the *V. parahaemolyticus* isolates, according to the procedure described by the manufacturer and using *V. parahaemolyticus* ATCC 33847 as the reference strain ([@B8]; [@B30]; [@B60]).

Detection of Virulence-Associated Genes
---------------------------------------

Detection of the *V. parahaemolyticus* virulence genes *tdh* ([@B56]) and *trh* ([@B38]) were also performed by PCR. We designed a primer for detection of the *ureR* gene to study the variation of the *trh* gene as outlined in [@B38]. The *ureR* gene encodes for the transcriptional activator of the urease gene cluster located immediately upstream from *trh* and is widely reported to be genetically linked to *trh* ([@B38]). *V. parahaemolyticus* virulence associated genes of type III secretion system-1 (T3SS1) genes (VP1670 \[*vscP*\], VP1686 \[*putative*\], VP1689 \[*vscK*\] and VP1694 \[*vscF*\]), T3SS2α genes (VP1362 \[*vopB2*\], VP1339 \[*vscC2*\], VP1335 \[*vscS2*\] and VP1327 \[*vopT*\]) and the T3SS2β genes (*vscC2*, *vopB2*, *vopC*, *vscS2*) were tested by conventional PCR ([@B26]). In our study, the oligonucleotide primers were synthesized by Sangon Biotech (Sangon Biotech, Shanghai, China). Particularly worth mentioning is that the *V. parahaemolyticus* ATCC17802 (*trh*+) and ATCC33847(*tdh*+) were used as the reference strains, and distilled water was used as the negative control.

Multilocus Sequence Typing
--------------------------

Seven housekeeping genes, *dnaE*, *gyrB*, *recA*, *dtdS*, *pntA*, *pyrC*, and *tnaA* (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), were used for *V. parahaemolyticus* characterization under the MLST scheme, PCR fragments were sequenced by Sangon Biotech (Sangon Biotech, Shanghai, China) and alignments of these sequences were determined using DNAMAN. The sequences were analyzed online^[1](#fn01){ref-type="fn"}^ to assign allele numbers and define sequence types (STs). New sequences for alleles and new ST profiles were submitted to the *V. parahaemolyticus* MLST database. Based on the relatedness of the STs, all of the isolates were subdivided into clonal complexes (CCs) or groups by eBURST program. Nucleotide sequence analyses were evaluated by MEGA5.1 program. In this study, the primary founder of a CC, a single locus variants (SLVs), double locus variants (DLVs), and singletons were defined as described previously ([@B17]).

Antimicrobial Susceptibility Testing
------------------------------------

The antibiotic susceptibilities of the 42 isolates were assessed using the disk diffusion method on Mueller Hinton agar (MHA) (OXOID Limited, China) according to the guidelines of the Clinical and Laboratory Standards Institute ([@B7]; [@B33]). Briefly, Muller--Hinton agar and a panel of 18 antibiotics disks were selected for resistance tests. The 18 common antimicrobials belonging to 6 classes used in this study were: β-lactam (ampicillin: AMP, amoxicillin-clavulanic: AMC, piperacillin: PRL, cefotaxime: CTX, ceftazidime: CAZ, cefoxitin: FOX, cephazolin: KZ, imipenem: IPM, meropenem: MEM), aminoglycoside (amikacin: AK, gentamicin: CN, kanamycin: K, streptomycin: S), tetracycline (tetracycline: TET), quinolone (ciprofloxacin: CIP, levofloxacin: LEV), sulfonamides (trimethoprim-sulfamethoxazole: SXT), chloramphenicol (chloramphenicol: C). The results were expressed as sensitive (S), intermediate (I), or resistant (R) according to the methods of the CLSI ([@B7]). *Escherichia coli* ATCC 25922 was used as the quality control organism for the antimicrobial susceptibility testing.

Evaluation of Antibiotic Resistance-Encoding Genes
--------------------------------------------------

The 38 antibiotic resistance genes (Supplementary Table [S2](#SM2){ref-type="supplementary-material"}) of six classes of antibiotics were identified by PCR, as previously described ([@B33]). All obtained PCR products were purified and sequenced by Sangon Biotech (Sangon Biotech, Shanghai, China). The acquired sequences were aligned and analyzed with the BLAST program^[2](#fn02){ref-type="fn"}^.

Results
=======

Prevalence of *V. parahaemolyticus*
-----------------------------------

A total of 42 presumptive *V. parahaemolyticus* strains were isolated from 1900 fecal specimens (2.2%) collected from patients presenting in Shanghai hospital during January, 2014 to December, 2015. The PCR results showed all isolates were positive for the presence of the *tlh* gene (**Table [1](#T1){ref-type="table"}**), which indicated that these 42 isolates were *V. parahaemolyticus* strains. And the results of API 20E and DBI-08 provided further evidence to the veracity of PCR outcomes, with all 42 isolates being identified with 99% confidence as *V. parahaemolyticus*. The demographic characteristics of patients about 42 *V. parahaemolyticus* isolates are also presented in **Table [1](#T1){ref-type="table"}**. The 42 individuals enrolled in this research included 20 females and 22 males. The male patients' ages ranged from 13 to 57, while for the female patients, the age distribution was more uniform in women whose median ages above 30 years-old.

###### 

Information of 42 *Vibrio parahaemolyticus* clinical isolates.

  Name     Gender   Age   *tlh*   *tdh*    *trh*    *ureR*
  -------- -------- ----- ------- -------- -------- --------
  VPC1     Female   57    ~+~     ~+~      **--**   **--**
  VPC2     Female   53    ~+~     ~+~      **--**   **--**
  VPC15    Female   30    ~+~     ~+~      **--**   **--**
  VPC16    Female   31    ~+~     ~+~      **--**   **--**
  VPC17    Male     56    ~+~     ~+~      **--**   **--**
  VPC18    Female   29    ~+~     **--**   ~+~      ~+~
  VPC19    Male     16    ~+~     ~+~      **--**   **--**
  VPC20    Male     13    ~+~     ~+~      **--**   **--**
  VPC21    Female   54    ~+~     ~+~      **--**   **--**
  VPC22    Male     17    ~+~     ~+~      **--**   **--**
  VPC25    Female   35    ~+~     ~+~      **--**   **--**
  VPC26    Female   36    ~+~     ~+~      **--**   **--**
  VPC27    Male     22    ~+~     ~+~      **--**   **--**
  VPC28    Male     48    ~+~     ~+~      **--**   **--**
  VPC29    Male     26    ~+~     ~+~      **--**   **--**
  VPC32    Male     57    ~+~     ~+~      **--**   **--**
  VPC33    Male     38    ~+~     ~+~      **--**   **--**
  VPC34    Male     37    ~+~     ~+~      **--**   **--**
  VPC35    Male     56    ~+~     ~+~      **--**   **--**
  VPC36    Female   47    ~+~     **--**   ~+~      ~+~
  VPC37    Male     63    ~+~     ~+~      **--**   **--**
  VPC38    Female   56    ~+~     ~+~      **--**   **--**
  VPC40    Female   58    ~+~     ~+~      **--**   **--**
  VPC41    Female   79    ~+~     ~+~      **--**   **--**
  VPC42    Male     55    ~+~     ~+~      **--**   **--**
  VPC43    Male     56    ~+~     ~+~      ~+~      ~+~
  VPC44    Male     33    ~+~     **--**   **--**   **--**
  VPC45    Female   54    ~+~     ~+~      **--**   **--**
  VPC46    Male     26    ~+~     ~+~      **--**   **--**
  VPC47    Female   86    ~+~     ~+~      **--**   **--**
  VPC48    Female   45    ~+~     ~+~      **--**   **--**
  VPC49    Female   56    ~+~     ~+~      ~+~      ~+~
  VPC50    Male     46    ~+~     ~+~      **--**   **--**
  VPC51    Male     24    ~+~     ~+~      **--**   **--**
  VPC54    Female   39    ~+~     ~+~      ~+~      ~+~
  VPC55    Male     22    ~+~     ~+~      **--**   **--**
  VPC85    Female   58    ~+~     **--**   ~+~      ~+~
  VPC89    Female   46    ~+~     ~+~      **--**   **--**
  VPC90    Male     37    ~+~     ~+~      **--**   **--**
  VPC94    Male     28    ~+~     **--**   ~+~      ~+~
  VPC97    Female   26    ~+~     ~+~      **--**   **--**
  VPC100   Male     56    ~+~     ~+~      **--**   **--**
                                                    

Distribution of Virulence-Associated Genes
------------------------------------------

From our study, the hemolysin gene *tdh* was detected in most of the isolates (88.1%, 37/42), whereas the *trh* gene was present in only 7 strains (16.7%, 7/42). We further determine the distribution of the *trh* gene by the *ureR* gene. The *ureR* gene and the variable *trh* gene were observed in the same seven *V. parahaemolyticus* isolates. Of these, 3 of 42 (7.1%) clinical isolates were positive for both *tdh* and *trh*. Only one strains (2.4%, 1/42) from the diarrheal patients contained neither the *tdh* nor the *trh* gene.

The two types of T3SS complexes are features in the virulence mechanism of *V. parahaemolyticus* and the distribution of T3SS genes is presented in **Table [2](#T2){ref-type="table"}**. T3SS1 genes were identified in all of the *V. parahaemolyticus* isolates and these samples contained all four T3SS1 genes (100%). All thirty-four of the *tdh*+/*trh*- and one of the *tdh*-/*trh*- clinical isolates contained all four genes of the T3SS2α genes. However, the isolates of *tdh*+/*trh*+ and *tdh*-/*trh*+ the detected percentage of all T3SS2α genes was only 33.3% and 50.0%, respectively. Additionally, four of the *tdh*-/*trh*+ isolates were amplified all four genes of the T3SS2β genes, followed by the isolates of *tdh*+/*trh*+ the detected percentage of all T3SS2β genes was 66.7%. Only one remaining *tdh*+/*trh*- isolate (VPC89) amplified all four T3SS2β genes but *vscC2*. As expected, one of the *tdh*-/*trh*- clinical isolate was evaluated in negative of all four T3SS2β genes. Overall, the T3SS2α-associated genes were most prevalent in *tdh*+ isolates (93.5%, 35/37), and the T3SS2β genes were detected prevalent in the *trh*+ clinical isolates (85.7%, 6/7).

###### 

Distribution of T3SS genes among 42 clinical *V. parahaemolyticus* isolates.

  Gene                      No. of strains (n = 42)           
  ------------------------- ------------------------- --- --- ---
  **T3SS1**                                                   
      VP1670 (*vscP*)       34                        3   4   1
      VP1686 (*putative*)   34                        3   4   1
      VP1689 (*vscK*)       34                        3   4   1
      VP1694 (*vscF*)       34                        3   4   1
  All 4 genes present       34                        3   4   1
  **T3SS2α**                                                  
      VP1362 (*vopB2*)      34                        2   3   1
      VP1339 (*vscC2*)      34                        1   3   1
      VP1335 (*vscS2*)      34                        1   2   1
      VP1327 (*vopT*)       34                        1   2   1
  All 4 genes present       34                        1   2   1
  **T3SS2β**                                                  
      *vscC2*               0                         3   4   0
      *vopB2*               1                         3   4   0
      *vopC*                1                         2   4   0
      *vscS2*               1                         3   4   0
  All 4 genes present       0                         2   4   0
                                                              

Multilocus Sequence Typing Analysis
-----------------------------------

The genetic characteristic of the *V. parahaemolyticus* isolates was analyzed by MLST. MLST classified the 42 *V. parahaemolyticus* isolates into 20 different STs (**Figure [1](#F1){ref-type="fig"}**), of which 16 ST were novel (ST1457, ST1458, ST1459, ST1460, ST1461, ST1462, ST1463, ST1464, ST1465, ST1466, ST1467, ST1468, ST1469, ST1470, ST1471, and ST1472). The go eBURST algorithm used in our study categorized 20 different STs into 10 singletons, one clone complexes (CC655) and Two groups (**Figure [2](#F2){ref-type="fig"}**). Among these, CC655 was the most prevalent clone complexes, including 22 isolates with ST655(50%), ST1464(36.4%), ST3(9.1%) and ST1468(4.5%). In addition, ST655 was the most frequent sequence type, which including 11 isolates (VPC16, VPC19 VPC20, VPC21, VPC22, VPC25, VPC27, VPC29, VPC33, VPC34, VPC97).

![Multilocus sequence typing (MLST) of 42 *V. parahaemolyticus* clinical isolates.](fmicb-08-01043-g001){#F1}

![The relationship between genetic diversity and virulence-associated genes characterization of isolates. ST, sequence type.](fmicb-08-01043-g002){#F2}

Antimicrobial Resistance Profile
--------------------------------

As shown in the **Table [3](#T3){ref-type="table"}**, the isolates of *V. parahaemolyticus* were detected for different levels of antibiotic resistance. One concern, all *V. parahaemolyticus* strains were resistant to ampicillin (100%) and streptomycin (100%), followed by Cephazolin (92.9%), Kanamycin (92.9%) and Amikacin (90.5%). Isolates were also commonly resistant to Gentamicin (71.4%), Piperacillin (54.8%), and Cefoxitin (50%). In addition, all the clinical isolates showed susceptibility to six antibiotics, including Chloramphenicol, Cefotaxime, Imipenem, Ceftazidime, Trimethoprim-sulfamethoxazole and Meropenem. And only one *V. parahaemolyticus* strains (VPC2) were not found in multidrug resistance (MDR, defined as resistance to 3 or more different antimicrobials). So the multidrug resistance rate reaches to 97.6% of all 42 clinical *V. parahaemolyticus* isolates. Of these, there were 92.9% multidrug-resistant isolates showing resistance to more than five antibiotics. Strikingly, we found that four isolates showed resistance to ten antibiotics.

###### 

Antimicrobial resistance profiles of 42 clinical *V. parahaemolyticus* isolates.

  Classify          Antimicrobial agent              *Vibrio parahaemolyticus* (*n* = 42)               
  ----------------- -------------------------------- -------------------------------------- ----------- ------------
  β- lactam         Ampicillin                       42 (100.0)                             0 (0.0)     0 (0.0)
                    Amoxicillin-Clavulanic           0 (0.0)                                8 (19.0)    34 (81.0)
                    Piperacillin                     7 (16.7)                               16 (38.1)   19 (45.2)
                    Cefotaxime                       0 (0.0)                                0 (0.0)     42 (100.0)
                    Ceftazidime                      0 (0.0)                                0 (0.0)     42 (100.0)
                    Cefoxitin                        0 (0.0)                                21 (50.0)   21 (50.0)
                    Cephazolin                       16 (38.1)                              23 (54.8)   3 (7.1)
                    Imipenem                         0 (0.0)                                0 (0.0)     42 (100.0)
                    Meropenem                        0 (0.0)                                0 (0.0)     42 (100.0)
  Tetracyclines     Tetracycline                     0 (0.0)                                2 (4.8)     40 (95.2)
  Aminoglycosides   Amikacin                         2 (4.8)                                36 (85.7)   4 (9.5)
                    Gentamicin                       3 (7.1)                                27 (64.3)   12 (28.6)
                    Kanamycin                        3 (7.1)                                36 (85.7)   3 (7.1)
                    Streptomyein                     30 (71.4)                              12 (28.6)   0 (0.0)
  Quinolones        Ciprofloxacin                    0 (0.0)                                11 (26.2)   31 (73.8)
                    Levofloxacin                     0 (0.0)                                2 (4.8)     40 (95.2)
  Chloramphenicol   Chloramphenicol                  0 (0.0)                                0 (0.0)     42 (100.0)
  Sulfonamides      Trimethoprim -sulfamethoxazole   0 (0.0)                                0 (0.0)     42 (100.0)
                                                                                                        

R, resistant; I, intermediate; S, sensitive.

Antimicrobial Resistance Genotypes of *V. parahaemolyticus*
-----------------------------------------------------------

The 38 antibiotic resistance genes of 6 classes of antibiotics searched in 42 pathogenic *V. parahaemolyticus* isolates are shown in Supplementary Table [S3](#SM3){ref-type="supplementary-material"}. Eight out of 38 resistance genes (*SHV*, *tet*(B), *str*A, *qnr*A, *gry*A, *qnr*B, *sul*I, *sul*II) were detected in at least one isolates. Notably, all of the clinical isolates carried two or more ARGs evaluated. Among them, *tet(*B) was the most prevalent gene, with the detection frequencies of 100%, followed by *str*A, *sul*I, *SHV*, *qnr*A, *qnr*B *gry*A, and *sul*II the detected percentage of them was 92.9, 90.5, 28.6, 28.6, 26.2,19.0, and 4.8%, respectively.

Correlation among Virulence genes, STs, Resistance Phenotype, and Genotype
--------------------------------------------------------------------------

A minimum spanning tree (MST) of the sequence types (STs) that was constructed based on subtyping information, including sequence type and virulence-associated genes, is shown in **Figure [2](#F2){ref-type="fig"}**. As shown in **Figure [2](#F2){ref-type="fig"}**, We can see that the most prevalent clonal complexes were CC655, all of them were positive for virulence-related *tdh* (100%), T3SS1(100%) genes and T3SS2α (100%) genes and the majority of them were negative for the *trh* (95.5%) and T3SS2β (95.5%) genes. Notably, two distinct lineages of the T3SS2 have been described with a correlation between the presence of *tdh* with T3SS2α and *trh* with T3SS2β. From this we can observe that the virulence-related gene of *trh* and T3SS2β are co-occurrences and disappearance simultaneously. Specifically, the *tdh* (100%), T3SS1(100%) genes and T3SS2α (100%) genes were detected in all ST655 isolates.

We conclude that correlation between virulence-related genes, AMR phenotypes and genotypes was absent. Likewise, as shown in **Figure [3](#F3){ref-type="fig"}**, genetic diversity is not apparently associated with the AMR phenotypes and genotypes.

![The relationship of genetic diversity, resistance phenotypic and genotypic characterization of 42 clinical *V. parahaemolyticus* isolates. ST, sequence type; R, resistant; I, intermediate; S, sensitive.](fmicb-08-01043-g003){#F3}

Discussion
==========

In this study, we analyzed 1900 fecal specimens collected from Shanghai hospital from January, 2014 to December, 2015 and isolated 42 *V. parahaemolyticus* strains, with an isolation rate of 2.2%. Compared to other studies in China, this rate is significantly less than the 6.0% reported for southern coastal China in 2007--2012 ([@B31]) and the 8.1% observed in southeastern China in 2009--2013 ([@B6]). Compared to other developing countries, our result is also less than the clinical *V. parahaemolyticus* isolation rate of 5.1% detected in Northwestern Mexico from 2004 to 2010 ([@B52]). That indicates the current status of *V. parahaemolyticus* infection in Shanghai is better than other regions.

The thermostable direct haemolysin (TDH), the TDH-related haemolysin (TRH) and the two type III secretion systems (T3SS1 and T3SS2) are recognized as major virulence factors in *V. parahaemolyticus* ([@B5]; [@B28]; [@B44]). In our study, the hemolysin gene *tdh* was detected in 88.1% *V. parahaemolyticus* isolates, whereas the *trh* gene was present in only 7 strains. And we found that one of the clinical isolates is co-negative for *tdh* and *trh* gene. This finding is consistent with prior studies that not all clinical strains harbor these genes ([@B39]). All *V. parahaemolyticus* strains in this study contains the T3SS1 component genes, which is also consistent with a previous study ([@B26]). The T3SS2 contains two gene clusters, T3SS2α and T3SS2β ([@B45]; [@B55]), which is closely related to *tdh*-positive and *trh*-positive *V. parahaemolyticus*, respectively ([@B26]). However, in this study, T3SS2α genes didn't appear with *tdh*+ genes simultaneously, which indicates that there is high genetic heterogeneity in *V. parahaemolyticus* T3SSs.

The genetic diversity of *V. parahaemolyticus* was also investigated using MLST. Compared to other molecular methods, such as the identification of known virulence genes, phylogenetic analysis of housekeeping genes, microarray, and PFGE, MLST give a better understanding of the genetic relationships among *V. parahaemolyticus* isolates ([@B42]; [@B18]; [@B34]). In this study, 42 *V. parahaemolyticus* isolates were classified into 20 sequence types (STs) with 16 novel STs. The high proportion of novel STs indicated a high genetic diversity of *V. parahaemolyticus* strains, and shows that the information content in the MLST database on this strain is still evolving. Thus, more MLST surveillances should be performed in China and the rest of world, to contributed to better understanding the genetic diversity of *V. parahaemolyticus*. Furthermore, ST655 was the most frequent hypotype in our study, which was clustered into the major clonal complex, CC655. Previous studies have been reported that ST3 belonged to the most prevalent clonal complex CC3, which is widely distributed and plays an important role in *V. parahaemolyticus* infections in multiple countries ([@B11]; [@B36]; [@B51]; [@B15]; [@B16]). There is only one locus difference between ST3 and ST655, which indicates that these STs are closely related. We recommend further research on the pandemic clonal complexes CC655 containing ST655 for management of *V. parahaemolyticus* infections.

Antibiotic treatment is necessary for controlling *V. parahaemolyticus* infections, but overuse of antibiotics has led to the generation and distribution of antimicrobial-resistant bacteria, which is becoming a major concern for human health ([@B25]; [@B47]; [@B3]). This study also investigated the antimicrobial resistance phenotype and genotype of the 42 clinical *V. parahaemolyticus* strains. All isolates showed a high level of resistance against Ampicillin (100.0%), Streptomycin (100.0%), Cephazolin (92.9%), Kanamycin (92.8%), and Amikacin (90.5%), and eight out of 38 resistance genes (*SHV*, *tet*(B), *str*A, *qnr*A, *gry*A, *qnr*B, *sul*I, *sul*II) were detected in at least two isolates. According to this study and some previous researches ([@B6]; [@B59]), the antimicrobial resistance of clinical *V. parahaemolyticus* was significantly higher than that of environmental strains which were isolated from water ([@B47]), aquatic products ([@B29]; [@B33]; [@B63]; [@B59]) or ready-to-eat foods ([@B60]). As the human gastrointestinal tract is a conducive environment for promoting horizontal ARGs transfer ([@B22]; [@B49]), we speculate that the complex gastrointestinal environment may accelerate the acquisition of antimicrobial resistance in *V. parahaemolytiucs*. The microevolution mechanisms for the different rates of acquisition of antibiotic resistance between clinical and environmental pathogens should be studied further.

Conclusion
==========

This study is the first comprehensive research describing the virulence, genetic diversity, antibiotic resistance phenotype, and genotype of *V. parahaemolyticus* from diarrhea patients in Shanghai. The study reveals that *tdh*, *trh* and T3SS genes are of equal importance as virulence associated factors. MLST analysis showed that the novel loci and STs points to high genetic diversity of *V. parahaemolyticus* strains isolated in Shanghai. ST655 was the most prevalent STs and this ST could have evolved from the global pandemic ST3. The antimicrobial resistance profiles indicated that the multidrug-resistant isolates were also widespread and measures to contain or slowdown the emergence of drug-resistant strains should be a top priority in China. These results add to the epidemiological data of clinical *V. parahaemolyticus* isolates in Shanghai and highlight the need for more AMR type research for managing the burden of disease caused by this pathogen in China.
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